{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T02:18:56Z","timestamp":1766110736685,"version":"3.48.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM130448"],"award-info":[{"award-number":["P20GM130448"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.vaccine.2025.128000","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T19:30:54Z","timestamp":1764012654000},"page":"128000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Vaccine candidate based on a baculovirus expressed VP2 provides full protection from epizootic hemorrhagic disease virus serotype 8 in calves"],"prefix":"10.1016","volume":"69","author":[{"given":"Massimo","family":"Spedicato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Profeta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Celani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Bonfini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gardenia","family":"Gatta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Ciarrocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Pulsoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Irelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juergen A.","family":"Richt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio","family":"Lorusso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2025.128000_bb0005","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.virusres.2009.07.012","article-title":"Genetic and phylogenetic analysis of the outer-coat proteins VP2 and VP5 of epizootic haemorrhagic disease virus (EHDV): comparison of genetic and serological data to characterise the EHDV serogroup","volume":"145","author":"Anthony","year":"2009","journal-title":"Virus Res"},{"issue":"2","key":"10.1016\/j.vaccine.2025.128000_bb0010","first-page":"95","article-title":"The nucleic acid and proteins of epizootic haemorrhagic disease virus","volume":"46","author":"Huismans","year":"1979","journal-title":"Onderstepoort J Vet Res"},{"issue":"5","key":"10.1016\/j.vaccine.2025.128000_bb0015","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.3390\/microorganisms11051339","article-title":"Epizootic Hemorrhagic disease virus: current knowledge and emerging perspectives","volume":"11","author":"Jim\u00e9nez-Cabello","year":"2023","journal-title":"Microorganisms"},{"issue":"5","key":"10.1016\/j.vaccine.2025.128000_bb0020","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3201\/eid2905.221773","article-title":"Epizootic Hemorrhagic disease virus serotype 8, Italy, 2022","volume":"29","author":"Lorusso","year":"2023","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128000_bb0025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/v15010016","article-title":"Epizootic haemorrhagic disease virus serotype 8 in Tunisia, 2021","volume":"15","author":"Sghaier","year":"2022","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.vaccine.2025.128000_bb0030","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3390\/v16030362","article-title":"Epidemiological analyses of the first incursion of the epizootic Hemorrhagic disease virus serotype 8 in Tunisia, 2021-2022","volume":"16","author":"Ben Hassine","year":"2024","journal-title":"Viruses"},{"issue":"2025","key":"10.1016\/j.vaccine.2025.128000_bb0035","article-title":"Description of the clinical findings associated with the epizootic Hemorrhagic disease in cattle from Northwestern Spain during the emergence","author":"D\u00edaz-Cao","year":"2025","journal-title":"Transbound Emerg Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2025.128000_bb0040","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3390\/v15071567","article-title":"Characterization of epizootic Hemorrhagic disease virus serotype 8 in naturally infected barbary deer (Cervus elaphus barbarus) and Culicoides (Diptera: Ceratopogonidae) in Tunisia","volume":"15","author":"Thabet","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2025.128000_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2024.199416","article-title":"Efficacy of an inactivated EHDV-8 vaccine in preventing viraemia and clinical signs in experimentally infected cattle","volume":"347","author":"Spedicato","year":"2024","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2025.128000_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2023.114808","article-title":"Development and validation of an RT-qPCR for detection and quantitation of emerging epizootic Hemorrhagic disease virus serotype 8 RNA from field samples","volume":"321","author":"Portanti","year":"2023","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2025.128000_bb0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-0716-4035-7_7","article-title":"Virus neutralization test for detecting and quantifying serum-neutralizing antibodies to epizootic Hemorrhagic disease virus (EHDV) (serotypes 1, 2, and 4-8)","volume":"2838","author":"Savini","year":"2024","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2025.128000_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2025.1562883","article-title":"Heterogenous within-herd seroprevalence against epizootic Hemorrhagic disease virus type 8 (EHDV-8) after massive virus circulation in cattle in France, 2023","volume":"12","author":"Anthonioz","year":"2025","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.vaccine.2025.128000_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2024.199489","article-title":"Exceptional bluetongue virus (BTV) and epizootic hemorrhagic disease virus (EHDV) circulation in France in 2023","volume":"350","author":"Gondard","year":"2024","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2025.128000_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2024.110069","article-title":"Emergence of epizootic Hemorrhagic disease in Red Deer (Cervus elaphus), Spain, 2022","volume":"292","author":"Ruiz-Fons","year":"2024","journal-title":"Vet Microbiol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2025.128000_bb0075","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.vetimm.2013.09.001","article-title":"Eradication of bluetongue disease in Germany by vaccination","volume":"158","author":"Baetza","year":"2014","journal-title":"Vet Immunol Immunopathol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128000_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085444","article-title":"Did vaccination slow the spread of bluetongue in France?","volume":"9","author":"Pioz","year":"2014","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2025.128000_bb0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.vetmic.2013.01.010","article-title":"Control of bluetongue in Europe","volume":"165","author":"Zientara","year":"2013","journal-title":"Vet Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2025.128000_bb0090","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/risa.14011","article-title":"Assessing the export trade risk of bluetongue virus serotypes 4 and 8 in France","volume":"43","author":"Zhang","year":"2023","journal-title":"Risk Anal"},{"issue":"12","key":"10.1016\/j.vaccine.2025.128000_bb0095","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01687-24","article-title":"Vaccine candidates based on MVA viral vectors expressing VP2 or VP7 confer full protection against epizootic hemorrhagic disease virus in IFNAR(\u2212\/\u2212) mice","volume":"98","author":"Jim\u00e9nez-Cabello","year":"2024","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128000_bb0100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/vaccines8010059","article-title":"Evaluation of a baculovirus-expressed VP2 subunit vaccine for the protection of white-tailed deer (Odocoileus virginianus) from epizootic Hemorrhagic disease","volume":"8","author":"Sunwoo","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"15","key":"10.1016\/j.vaccine.2025.128000_bb0105","article-title":"Co-expression of VP2, NS1 and NS2-Nt proteins by an MVA viral vector induces complete protection against bluetongue virus","author":"Jim\u00e9nez-Cabello","year":"2024","journal-title":"Front Immunol"},{"year":"2024","series-title":"Enfermedad Hemorr\u00e1gica Epizo\u00f3tica en Espa\u00f1a\u202f: impacto en zoos y parques de fauna en semilibertad. I International Congress ENZOEM: Emerging Diseases: New horizons from a One health perspective. 5-7 February 2024","author":"Mu\u00f1oz-Fern\u00e1ndez","key":"10.1016\/j.vaccine.2025.128000_bb0110"},{"year":"2024","series-title":"Enfermedad hemorr\u00e1gica epizo\u00f3tica en rumiantes silvestres en Espa\u00f1a: impacto cl\u00ednico-lesional en ciervo rojo (Cervus elaphus). III International Congress of Animal Health and Welfare. 14-16 November 2024","author":"Mu\u00f1oz-Fern\u00e1ndez","key":"10.1016\/j.vaccine.2025.128000_bb0115"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25012988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25012988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T02:07:41Z","timestamp":1766110061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25012988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":23,"alternative-id":["S0264410X25012988"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128000","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine candidate based on a baculovirus expressed VP2 provides full protection from epizootic hemorrhagic disease virus serotype 8 in calves","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128000","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128000"}}